オープン アクセスを義務付けられた論文 - Howard McLeod詳細
一般には非公開: 31 件
CYP2D6 and tamoxifen: DNA matters in breast cancer
JM Hoskins, LA Carey, HL McLeod
Nature Reviews Cancer 9 (8), 576-586, 2009
委任: US National Institutes of Health
Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis.
P Ranganathan, R Culverhouse, S Marsh, A Mody, TJ Scott-Horton, ...
The Journal of rheumatology 35 (4), 572-579, 2008
委任: US National Institutes of Health
Genetic and clinical factors relating to warfarin dosing
DE Jonas, HL McLeod
Trends in pharmacological sciences 30 (7), 375-386, 2009
委任: US National Institutes of Health
Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes
T Fukami, M Nakajima, T Maruichi, S Takahashi, M Takamiya, Y Aoki, ...
Pharmacogenetics and genomics 18 (10), 911-920, 2008
委任: US National Institutes of Health
Exome resequencing identifies potential tumor‐suppressor genes that predispose to colorectal cancer
CG Smith, M Naven, R Harris, J Colley, H West, N Li, Y Liu, R Adams, ...
Human mutation 34 (7), 1026-1034, 2013
委任: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Rates and risk of atrial arrhythmias in patients treated with ibrutinib compared with cytotoxic chemotherapy
MG Fradley, M Gliksman, J Emole, F Viganego, I Rhea, A Welter-Frost, ...
The American journal of cardiology 124 (4), 539-544, 2019
委任: US National Institutes of Health
PARPi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer
D Shen, J Luo, L Chen, W Ma, X Mao, Y Zhang, J Zheng, Y Wang, J Wan, ...
Cancer Letters 550, 215919, 2022
委任: National Natural Science Foundation of China
Propranolol Suppresses the Growth of Colorectal Cancer Through Simultaneously Activating Autologous CD8+ T Cells and Inhibiting Tumor AKT/MAPK Pathway
P Liao, K Song, Z Zhu, Z Liu, W Zhang, W Li, J Hu, Q Hu, C Chen, B Chen, ...
Clinical Pharmacology & Therapeutics 108 (3), 606-615, 2020
委任: National Natural Science Foundation of China
Use of CYP2D6 Genotyping in Practice: Tamoxifen Dose Adjustment
CM Walko, H McLeod
Pharmacogenomics 13 (6), 691-697, 2012
委任: US National Institutes of Health
Colorectal cancer cell lines lack the molecular heterogeneity of clinical colorectal tumors
JT Auman, HL McLeod
Clinical Colorectal Cancer 9 (1), 40-47, 2010
委任: US National Institutes of Health
Association of thymidylate synthase variants with 5-fluorouracil cytotoxicity
EJ Peters, AT Kraja, SJ Lin, JL Yen-Revollo, S Marsh, MA Province, ...
Pharmacogenetics and genomics 19 (5), 399-401, 2009
委任: US National Institutes of Health
The pharmacogenetics of medications used in general anesthesia
S Xie, W Ma, Q Guo, J Liu, W Li, HL McLeod, Y He
Pharmacogenomics 19 (3), 285-298, 2018
委任: National Natural Science Foundation of China
EBV infection and MSI status significantly influence the clinical outcomes of gastric cancer patients
H Shen, M Zhong, W Wang, P Liao, X Yin, D Rotroff, TC Knepper, ...
Clinica Chimica Acta 471, 216-221, 2017
委任: National Natural Science Foundation of China
UGT1A and irinotecan toxicity: keeping it in the family
JM Hoskins, HL McLeod
Journal of Clinical Oncology 27 (15), 2419-2421, 2009
委任: US National Institutes of Health
Harnessing economic drivers for successful clinical implementation of pharmacogenetic testing
PA Deverka, HL McLeod
Clinical Pharmacology & Therapeutics 84 (2), 191-193, 2008
委任: US National Institutes of Health
Pharmacogenomic contribution to drug response
RG Watson, HL McLeod
The Cancer Journal 17 (2), 80-88, 2011
委任: US National Institutes of Health
Adherence to adjuvant imatinib therapy in patients with gastrointestinal stromal tumor in clinical practice: a cross-sectional study
Y Wang, P Zhang, Y Han, RS Nelson, HL McLeod, K Tao, Y Yuan, ...
Chemotherapy 64 (4), 197-204, 2020
委任: National Natural Science Foundation of China
The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference
RH He, YJ He, YJ Tang, HH Zhou, HL McLeod, J Liu
Pharmacogenomics 17 (59), 74-9, 2016
委任: National Natural Science Foundation of China
Cancer pharmacogenomics, adoption by oncologists and patient benefit
LG Dressler, AM Deal, J Patel, J Markey, MV Riper, HL McLeod
Personalized Medicine 11 (2), 143-153, 2014
委任: US National Institutes of Health
Novel tagging SNP rs1495741 and 2-SNPs (rs1041983 and rs1801280) yield a high prediction of the NAT2 genotype in HapMap samples
YJ He, MH Shapero, HL Mcleod
Pharmacogenetics and genomics 22 (4), 322-324, 2012
委任: US National Institutes of Health
公開と助成金に関する情報は、コンピュータ プログラムによって自動的に決定されます